Premium
Local experience with the novel human anti‐CD20 antibody, ofatumumab, as salvage treatment for patients with heavily pretreated chronic lymphocytic leukaemia
Author(s) -
Cheah C. Y.,
Carney D. A.,
Lim S. M.,
Januszewicz H.,
Scarlett J.,
Seymour J. F.
Publication year - 2012
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/j.1445-5994.2012.02827.x
Subject(s) - medicine , hematology , cancer , chronic lymphocytic leukemia , oncology , leukemia